Answers are grounded in this paper and cite their sources.
Background & Aims Accurate evaluation of liver fibrosis is crucial for predicting progression of chronic hepatitis B virus (HBV) infection. We assessed the utility of a novel fibrosis glycobiomarker Wisteria floribunda agglutinin‐positive Mac‐2‐binding protein (WFA+‐M2BP) for evaluating liver fibrosis and disease progression in patients with chronic HBV infection. Methods We enrolled 774 patients with chronic HBV infection, with or without fibrosis, diagnosed by liver biopsy/FibroScan. Patients who underwent liver biopsy (n = 297) were divided into training (n = 221) and validation (n = 76) groups. Serum WFA+‐M2BP values were measured and compared with FIB‐4 index, aspartate aminotransferase (AST)‐to‐platelet ratio (APRI) and AST‐to‐alanine aminotransferase ratio (AAR) using receiver‐operating characteristic (ROC) analysis. Results Serum WFA+‐M2BP levels increased significantly with fibrosis progression (P < 0.0001). Area under the ROC curve of WFA+‐M2BP for diagnosing significant fibrosis was higher than that of FIB‐4 (P = 0.198), APRI (P = 0.017) and AAR (P < 0.001), with sensitivity and specificity in the training set of 60.5% and 79.8% and validation set of 59.5% and 82.1%, respectively. Serum WFA+‐M2BP levels were significantly correlated with FibroScan values (P < 0.0001) and improved the accuracy of FibroScan in assessing significant fibrosis. Changes in WFA+‐M2BP levels were parallel with those in FibroScan values during nucleot(s)ide analogues therapy in patients with chronic HBV infection. Conclusions WFA+‐M2BP is an accurate serum indicator for assessing early stages of liver fibrosis and may monitor regression of fibrosis during the treatment of chronic HBV infection. WFA+‐M2BP provides a simple and reliable alternative or complementary method to liver biopsy and FibroScan.
No takes yet. Share an insight, caveat, or question.
Zou et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: